ABCB4 Gene Mutations in Intrahepatic Cholestasis of Pregnancy and Controls
Mutations and Polymorphisms of Gene ABCB4 Among Women Suffering From Intrahepatic Cholestasis of Pregnancy. A Study With a Control Group.
1 other identifier
observational
120
1 country
1
Brief Summary
Mutations of the ATP binding cassette subfamily B member 4 (ABCB4) gene, a gene involved in a subtype of progressive familial intrahepatic cholestasis, have been reported in women suffering from intrahepatic cholestasis of pregnancy. The true incidence and the role of these ABCB4 gene mutations in patients suffering from intrahepatic cholestasis of pregnancy have not been clearly established. The aim of the present study is to describe the nature and frequency of these mutations in a series of patients with intrahepatic cholestasis of pregnancy and to compare with a control group of pregnant women without intrahepatic cholestasis of pregnancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2006
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2006
CompletedFirst Submitted
Initial submission to the registry
June 13, 2008
CompletedFirst Posted
Study publicly available on registry
June 18, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2009
CompletedJune 17, 2010
June 1, 2010
2 years
June 13, 2008
June 16, 2010
Conditions
Keywords
Study Arms (1)
1
Normal multiparous pregnant women without intrahepatic cholestasis of pregnancy (control group)
Eligibility Criteria
multiparous normal pregnant women (control group)from a single University center
You may qualify if:
- pregnant woman (age \> 18 years) during the third trimester
- caucasian and born in France
- multiparous (with at least 2 full term pregnancies)
- with informed written consent
You may not qualify if:
- generalized pruritus and/or liver disease during pregnancy
- liver disease secondary to oral contraception
- Chronic liver disease
- disease during current pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de Gynécologie Obstétrique CHRU Tours
Tours, 37044, France
Biospecimen
blood samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
BACQ Yannick, MD
Service d'hépato-gastro-entérologie CHRU Tours
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 13, 2008
First Posted
June 18, 2008
Study Start
July 1, 2006
Primary Completion
July 1, 2008
Study Completion
July 1, 2009
Last Updated
June 17, 2010
Record last verified: 2010-06